AN
Andrei Nikolaevich Medunitsyn
About Andrei Nikolaevich Medunitsyn
Data last updated:
Andrei Nikolaevich Medunitsyn is a Director at Oxford Laboratories Private Limited (since 2000) and Director at Oxford Lifesciences Private Limited (since 2003). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹69.88 Cr; the largest is Oxford Laboratories Private Limited at ₹67.77 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Oxford Laboratories Private Limited U24230MH2000PTC123927 | Director | 31 Jan 2000 | 2000 | ₹67.77 Cr (FY 2025) | Active |
| Oxford Lifesciences Private Limited U24230MH2003PTC139562 | Director | 12 Mar 2003 | 2003 | ₹2.11 Cr (FY 2025) | Active |
Board colleagues of Andrei Nikolaevich Medunitsyn
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyajeet Sumant Khanolkar | 00322818 | Oxford Laboratories Private Limited , Oxford Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Andrei Nikolaevich Medunitsyn
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Andrei Nikolaevich Medunitsyn
Andrei Nikolaevich Medunitsyn currently holds 2 directorships: Oxford Laboratories Private Limited (Director, since 31 Jan 2000, revenue ₹67.77 Cr (FY 2025)); Oxford Lifesciences Private Limited (Director, since 12 Mar 2003, revenue ₹2.11 Cr (FY 2025)).
Andrei Nikolaevich Medunitsyn was first appointed on 31 Jan 2000 as Director at Oxford Laboratories Private Limited. The most recent appointment on record is 12 Mar 2003 at Oxford Lifesciences Private Limited.
The 2 current companies of Andrei Nikolaevich Medunitsyn that report revenue have a combined latest revenue of ₹69.88 Cr: Oxford Laboratories Private Limited ₹67.77 Cr (FY 2025); Oxford Lifesciences Private Limited ₹2.11 Cr (FY 2025).
The current boards of Andrei Nikolaevich Medunitsyn's companies include Satyajeet Sumant Khanolkar (Oxford Laboratories Private Limited).